For hundreds of millions of people around the world, gastrointestinal symptoms significantly impact their quality of life on a daily basis. Simple pleasures such as going out to dinner, practicing sports or spending time with friends are spoiled by debilitating abdominal pain, bloating, or transit disorders such as diarrhea and constipation. To live with these symptoms, many embark on a complex medical journey with multiple solutions in search of relief.
IbSium® (Saccharomyces cerevisiae CNCM I-3856), a unique probiotic yeast developed by Gnosis by Lesaffre, introduces a new way to alleviate these symptoms. Four clinical studies have shown that this strain may not only significantly alleviate occasional gastrointestinal symptoms but may also improve overall quality of life (reduce food avoidance, improve body image, lessen interference with activities).
Beyond its efficacy, this breakthrough probiotic yeast strain does not need to be refrigerated and offers a three-year shelf life.
IbSium® is the result of real teamwork and collaboration over the past 10 years, which has allowed us to build the science behind this ingredient.
To find out more on IbSium®, click here.